Nucala (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the Nucala drug offered from GlaxoSmithKline LLC. This Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | mepolizumab |
| SUBSTANCE NAME: | MEPOLIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-11-04 |
| END MARKETING DATE: | 0000-00-00 |
Nucala HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nucala from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2015-11-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0881_3663c3fb-5ee9-429c-be9b-4767601a7c8f |
| PRODUCT NDC: | 0173-0881 |
| APPLICATION NUMBER: | BLA125526 |
Other MEPOLIZUMAB Pharmaceutical Manufacturers / Labelers:
